Table 2 Clinical characteristics of patients
 |  |  |  | Gleason |  | PSA at diagnosis | PSA nadir |
---|---|---|---|---|---|---|---|
ID | Age | Ethnicity | Race | Score | TNM stage | ng/mL | ng/mL |
UM10001 | 67 | NH | C | 9 | T4N1M1 | 2.40 | 0.32 |
UM10003 | 53 | NH | C | 9 | TxNxM1 | 114.10 | <0.01 |
UM10029 | 62 | NH | C | 7 | TxNxMx | 7.96 | 0.1 |
UM10035 | 61 | NH | C | 9 | T2N1M0 | 9.48 | <0.01 |
UM10055 | 62 | NH | C | 7 | TxN1Mx | 9.20 | 0.1 |
UM10099 | 59 | NH | B | 9 | TxNxMx | 285.70 | 10.8 |